<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36371546</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-896X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Protein science : a publication of the Protein Society</Title><ISOAbbreviation>Protein Sci</ISOAbbreviation></Journal><ArticleTitle>Biophysical characterization of full-length TAR DNA-binding protein (TDP-43) phase separation.</ArticleTitle><Pagination><StartPage>e4509</StartPage><MedlinePgn>e4509</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e4509</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/pro.4509</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions are associated with deposition of cytosolic inclusion bodies of TAR DNA-binding protein 43 (TDP-43) in brain and motor neurons. We induced phase separation of purified full-length TDP-43 devoid of large tags using a solution-jump method, and monitored it with an array of biophysical techniques. The tetramethylrhodamine-5-maleimide- or Alexa488-labeled protein formed rapidly (&lt;1&#x2009;min) apparently round, homogeneous and 0.5-1.0&#xa0;&#x3bc;m wide assemblies, when imaged using confocal fluorescence, bright-field, and stimulated emission depletion microscopy. The assemblies, however, had limited internal diffusion, as assessed with fluorescence recovery after photobleaching, and did not coalesce, but rather clustered into irregular bunches, unlike those formed by the C-terminal domain. They were enriched with &#x3b1;-helical structure, with minor contributions of &#x3b2;-sheet/random structure, had a red-shifted tryptophan fluorescence and did not bind thioflavin T. By monitoring with turbidimetry both the formation of the spherical species and their further clustering under different experimental conditions, we carried out a multiparametric analysis of the two phenomena. In particular, both processes were found to be promoted by high protein concentrations, salts, crowding agents, weakly by reducing agents, as the pH approached a value of 6.0 from either side (corresponding to the TDP-43 isoionic point), and as the temperature approached a value of 31&#xb0;C from either side. Important differences were found with respect to the TDP-43 C-terminal domain. Our multiparametric results also provide explanations to some of the solubility data obtained on full-length TDP-43 that were difficult to explain following the multiparametric analysis acquired on the C-terminal domain.</AbstractText><CopyrightInformation>&#xa9; 2022 The Protein Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Staderini</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6993-4408</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigi</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1067-6288</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongiello</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchi</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8387-7737</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1330-1289</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Protein Sci</MedlineTA><NlmUniqueID>9211750</NlmUniqueID><ISSNLinking>0961-8368</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">liquid-liquid phase separation</Keyword><Keyword MajorTopicYN="N">motor neuron diseases</Keyword><Keyword MajorTopicYN="N">recombinant TDP-43</Keyword><Keyword MajorTopicYN="N">self-assembly</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36371546</ArticleId><ArticleId IdType="pmc">PMC9703588</ArticleId><ArticleId IdType="doi">10.1002/pro.4509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T, Hasegawa M, Akiyama H, et al. TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumannn M, Bigio EH, et al. Nomenclature forneuropathologic subtypesof frontotemporal lobar degeneration: Consensus recommendations. Acta Neuropathol. 2009;117:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710877</ArticleId><ArticleId IdType="pubmed">19015862</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14:248&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW. The seeds of neurodegeneration: Prion&#x2010;like spreading in ALS. Cell. 2011;147:498&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Lee VMY, Trojanowski JQ. TDP&#x2010;43 functions and pathogenic mechanisms implicated in TDP&#x2010;43 proteinopathies. Trends Mol Med. 2011;17:659&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, et al. Molecular basis of UG&#x2010;rich RNA recognition by the human splicing factor TDP&#x2010;43. Nat Struct Mol Biol. 2013;20:1443&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday G, Bigio EH, Cairns NJ, Neumann M, Mackenzie IR, Mann DM. Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects. Acta Neuropathol. 2012;124:373&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3445027</ArticleId><ArticleId IdType="pubmed">22878865</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, Capitini C, Fani G, Dobson CM, Cecchi C, Chiti F. Quantification of the relative contributions of loss&#x2010;of&#x2010;function and gain&#x2010;of&#x2010;function mechanisms in TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) proteinopathies. J Biol Chem. 2016;291:19437&#x2013;19448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5016682</ArticleId><ArticleId IdType="pubmed">27445339</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador&#x2010;Ortiz C, Lin WL, Ahmed Z, et al. TDP&#x2010;43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol. 2007;61:435&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima&#x2010;Yasuda H, Uryu K, Robinson J, et al. Co&#x2010;morbidity of TDP&#x2010;43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114:221&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">17653732</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation&#x2010;responsive DNA&#x2010;binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp. 2008;67:1159&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">19018245</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh RH. TDP&#x2010;43: The relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J. 2011;278:3539&#x2013;3549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177991</ArticleId><ArticleId IdType="pubmed">21777387</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao PPN, Shakeri A, Zhao Y, Calon F. Strategies in the design and development of (TAR) DNA&#x2010;binding protein 43 (TDP&#x2010;43) binding ligands. Eur J Med Chem. 2021;225:113753.</Citation><ArticleIdList><ArticleId IdType="pubmed">34388383</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A, Zerze G, Mittal J, Fawzi N. ALS mutations disrupt phase separation mediated by &#x3b1;&#x2010;helical structure in the TDP&#x2010;43 low&#x2010;complexity C&#x2010;terminal domain. Structure. 2016;24:1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HR, Chiang WC, Chou PC, Wang WJ, Huang JR. TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) liquid&#x2013;liquid phase separation is mediated by just a few aromatic residues. J Biol Chem. 2018;293:6090&#x2013;6098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D'Ambrogio A, et al. Structural determinants of the cellular localization and shuttling of TDP&#x2010;43. J Cell Sci. 2008;121:3778&#x2013;3785.</Citation><ArticleIdList><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y, Arima K, Tabunoki H, Satoh J. TDP&#x2010;43 dimerizes in human cells in culture. Cell Mol Neurobiol. 2010;30:641&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu TH, Wu CY, et al. The N&#x2010;terminus of TDP&#x2010;43 promotes its oligomerization and enhances DNA binding affinity. Biochem Biophys Res Commun. 2012;425:219&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">22835933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Caulfield T, Xu YF, et al. The dual functions of the extreme N&#x2010;terminus of TDP&#x2010;43 in regulating its biological activity and inclusion formation. Hum Mol Genet. 2013;22:3112&#x2013;3122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YT, Kuo PH, Chiang CH, et al. The truncated C&#x2010;terminal RNA recognition motif of TDP&#x2010;43 protein plays a key role in forming proteinaceous aggregates. J Biol Chem. 2013;288:9049&#x2013;9057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610977</ArticleId><ArticleId IdType="pubmed">23372158</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, Hock EM, Ernst P, et al. Functional and dynamic polymerization of the ALS&#x2010;linked protein TDP&#x2010;43 antagonizes its pathologic aggregation. Nat Commun. 2017;8:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, et al. A single N&#x2010;terminal phosphomimic disrupts TDP&#x2010;43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, et al. JQ pathological TDP&#x2010;43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP&#x2010;43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana MT, Piccinini M, Grifoni S, et al. TDP&#x2010;43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010;20:351&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094784</ArticleId><ArticleId IdType="pubmed">19338576</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph A, Thal DR, Del Tredici K. Amyotrophic lateral sclerosis: Dash&#x2010;like accumulation of phosphorylated TDP&#x2010;43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010;120:67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">20379728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, et al. Phosphorylated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64:60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WL, Dickson DW. Ultrastructural localization of TDP&#x2010;43in filamentous neuronal inclusions in various neurodegenera&#x2010;tive diseases. Acta Neuropathol. 2008;116:205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2706695</ArticleId><ArticleId IdType="pubmed">18607609</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorpe JR, Tang H, Atherton J, Cairns NJ. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP&#x2010;43 proteinopathy. J Neural Transm. 2008;115:1661&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789307</ArticleId><ArticleId IdType="pubmed">18974920</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, Hasegawa M, Murzin AG, et al. Structure of pathological TDP&#x2010;43 filaments from ALS with FTLD. Nature. 2022;601:139&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, Liu NH, Croul S, et al. Amyotrophic lateral sclerosis is a non&#x2010;amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119:335&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">20111867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Neumann M, Bigio EH, et al. TDP&#x2010;43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol. 2007;171:227&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitini C, Conti S, Perni M, et al. TDP&#x2010;43 inclusion bodies formed in bacteria are structurally amorphous, non&#x2010;amyloid and inherently toxic to neuroblastoma cells. PLoS One. 2014;9:e86720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3907574</ArticleId><ArticleId IdType="pubmed">24497973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Medina Cruz A, Hadley KC, et al. Physiologically important electrolytes as regulators of TDP&#x2010;43 aggregation and droplet&#x2010;phase behavior. Biochemistry. 2019;58:590&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">30489059</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Zennaro E, Fallini C, et al. TDP&#x2010;43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111:1051&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Cohen T. Aggregation of the nucleic acid&#x2010;binding protein TDP&#x2010;43 occurs via distinct routes that are coordinated with stress granule formation. J Biol Chem. 2019;294:3696&#x2013;3706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416430</ArticleId><ArticleId IdType="pubmed">30630951</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Lee VM, Trojanowksi JQ, Van Deerlin MV, Lee EB, Bonini NM. Poly&#x2010;A binding protein&#x2010;1 localization to a subset of TDP&#x2010;43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72 . J Neuropathol Exp. 2014;73:837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4149258</ArticleId><ArticleId IdType="pubmed">25111021</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset&#x2010;Rosa F, Lu S, Yu H, et al. Cytoplasmic TDP&#x2010;43 de&#x2010;mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP&#x2010;43, and cell death. Neuron. 2019;102:339&#x2013;357.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Duan Y, Duan G, et al. Stress induces dynamic, cytotoxicity&#x2010;antagonizing TDP&#x2010;43 nuclear bodies via paraspeckle LncRNA NEAT1&#x2010;mediated liquid&#x2010;liquid phase separation. Mol Cell. 2020;79:443&#x2013;458.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, Nakagawa S, Hirose T, et al. The long non&#x2010;coding RNA nuclear&#x2010;enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain. 2013;6:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Narsa MR, Shen CKJ. Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci U S A. 2002;99:13583&#x2013;13588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129717</ArticleId><ArticleId IdType="pubmed">12361981</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan&#x2010;Johns M, Bengoechea R, Bell S, et al. Prion&#x2010;like nuclear aggregation of TDP&#x2010;43 during heat shock is regulated by HSP40/70 chaperones. Hum Mol Genet. 2014;23:157&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F, Glasebach H, Kahle P. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP&#x2010;43 protein independent of its translocation into stress granules. J Biol Chem. 2020;295:673&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="pubmed">31780563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Gumina V, Lenzi P, et al. Chronic stress induces formation of stress granules and pathological TDP&#x2010;43 aggregates in human ALS fibroblasts and iPSC&#x2010;motoneurons. Neurobiol Dis. 2020;145:105051.</Citation><ArticleIdList><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM, Haider R, Dumm BK, et al. The role of liquid&#x2013;liquid phase separation in aggregation of the TDP&#x2010;43 low&#x2010;complexity domain. J Biol Chem. 2019;294:6306&#x2013;6317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L, et al. Poly(ADP&#x2010;ribose) prevents pathological phase separation of TDP&#x2010;43 by promoting liquid demixing and stress granule localization. Mol Cell. 2018;71:703&#x2013;717.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Le J, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruijs da Silva LA, Simonetti F, Hutten S, et al. Disease&#x2010;linked TDP&#x2010;43 hyperphosphorylation suppresses TDP&#x2010;43 condensation and aggregation. EMBO J. 2022;41:e108443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Comert F, Dubin PL. Liquid&#x2010;liquid and liquid&#x2010;solid phase separation in protein&#x2010;polyelectrolyte systems. Adv Colloid Interface Sci. 2017;239:213&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">27773339</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivoli Vega M, Nigro A, Luti S, et al. Isolation and characterization of soluble human full&#x2010;length TDP&#x2010;43 associated with neurodegeneration. FASEB J. 2019;33:10780&#x2013;10793.</Citation><ArticleIdList><ArticleId IdType="pubmed">31287959</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang YS, Tsai KJ, Chang YJ, et al. Full&#x2010;length TDP&#x2010;43 forms toxic amyloid oligomers that are present in frontotemporal lobal dementia&#x2010;TDP patients. Nat Commun. 2014;5:4824.</Citation><ArticleIdList><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Doke AA, Jha SK. Effect of In vitro solvation conditions on inter&#x2010; and intramolecular assembly of full&#x2010;length TDP&#x2010;43. J Phys Chem B. 2022;126:4799&#x2013;4813.</Citation><ArticleIdList><ArticleId IdType="pubmed">35758053</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine H 3rd. Thioflavin T interaction with synthetic Alzheimer's disease beta&#x2010;amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993;2:404&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2142377</ArticleId><ArticleId IdType="pubmed">8453378</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Lin YT, Chang D, Guo Z. Thioflavin T as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation. R Soc Open Sci. 2017;4:160696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5319338</ArticleId><ArticleId IdType="pubmed">28280572</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi KJ, Tsoi PS, Moosa MM, et al. A chemical chaperone decouples TDP&#x2010;43 disordered domain phase separation from fibrillation. Biochemistry. 2018;57:6822&#x2013;6826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6555487</ArticleId><ArticleId IdType="pubmed">30520303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaur EL. Amyotrophic lateral sclerosis&#x2010;linked mutations increase the viscosity of liquid&#x2010;like TDP&#x2010;43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114:E2466&#x2013;E2475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, Banchelli M, Ghadami SA, et al. An in situ and in vitro investigation of cytoplasmic TDP&#x2010;43 inclusions reveals the absence of a clear amyloid signature. Ann&#xa0;Med. 2022; 54. 10.1080/07853890.2022.2148734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2148734</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Lindt J, Bratek&#x2010;Skicki A, Nguyen PN, et al. A generic approach to study the kinetics of liquid&#x2013;liquid phase separation under near&#x2010;native conditions. Commun Biol. 2021;4:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7815728</ArticleId><ArticleId IdType="pubmed">33469149</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmann TM, Alberti S. Prion&#x2010;like low&#x2010;complexity sequences: Key regulators of protein solubility and phase behavior. J Biol Chem. 2018;294:7128&#x2013;7136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509491</ArticleId><ArticleId IdType="pubmed">29921587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott TJ, Petsalaki E, Farber P, et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organless. Mol Cell. 2015;57:936&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352761</ArticleId><ArticleId IdType="pubmed">25747659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff KM, Roberts S, Chilkoti A, Pappu RV. Advances in understanding stimulus&#x2010;responsive phase behavior of intrinsically disordered protein polymers. J Mol Biol. 2018;230:4619&#x2013;4635.</Citation><ArticleIdList><ArticleId IdType="pubmed">29949750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberger F, Howard SB, Sowers JW, Nyce TA. Temperature dependence of protein solubility&#x2014;Determination and application to crystallization in X&#x2010;ray capillaries. J Cryst Growth. 1993;129:1&#x2013;12.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>